← All decks

General Surgery

Cancers of the Periampullary Region and the Pancreas

Built from Maingot's Abdominal Operations

The first 25 slides of Cancers of the Periampullary Region and the Pancreas
The first 25 slides, exactly as they appear. The full deck has 160 content slides.

What’s inside

22 sections · 160 slides

  1. 01

    Overview

    • Scope of this presentation

    1 slide

  2. 02

    What periampullary cancer means

    Four tumours, one small piece of anatomy

    • Definition of periampullary cancer
    • Rationale for grouping the four cancers
    • Anatomical origins of periampullary cancer
    • Early attempts at resection
    • Establishment of pancreaticoduodenectomy
    • ~2%

    6 slides

  3. 03

    Incidence and epidemiology

    How common, where, and in whom

    • Burden of pancreatic cancer in the United States
    • Geographic trends and demographic distribution

    2 slides

  4. 04

    Pathology

    What the tumours are made of

    • Adenocarcinoma as the dominant histology
    • Site of origin of periampullary adenocarcinoma
    • Uncommon tumours of the periampullary region
    • Distribution of pancreatic ductal adenocarcinoma
    • Pancreatic endocrine and cystic neoplasms

    5 slides

  5. 05

    Risk factors

    What is proven, what is weak, what is myth

    • Established and weak environmental risk factors
    • Evidence linking cigarette smoking to pancreatic cancer
    • Dietary associations
    • Exposures with little or no established risk
    • Chronic pancreatitis and diabetes as risk factors
    • Risk factors for the non-pancreatic periampullary cancers
    • Hereditary syndromes predisposing to pancreatic cancer
    • Familial pancreatic cancer and polyposis syndromes

    8 slides

  6. 06

    Genetic alterations

    What sequencing the tumour genome showed

    • Genomic tools applied to cancer
    • The pancreatic cancer genome project
    • Frequency of the commonest gene alterations
    • Genetics of ampullary adenocarcinoma

    4 slides

  7. 07

    Clinical presentation

    Symptoms, signs and laboratory findings

    • Aim of the workup and timing of symptoms
    • Symptoms of obstructive jaundice
    • Mechanism of obstructive jaundice
    • Pain and gastric outlet obstruction
    • Subtle presentations and presentation by site
    • Physical findings on examination
    • Physical signs of advanced disease
    • Laboratory findings in biliary obstruction
    • CA 19-9 and molecular markers

    9 slides

  8. 08

    Imaging studies

    Choosing the test that answers the question

    • Imaging modalities and the shift to noninvasive tests
    • Choosing an imaging test
    • Role of right upper quadrant ultrasonography
    • Multidetector spiral CT in diagnosis and staging
    • Dilated intrahepatic bile ducts on CT
    • Double-duct sign on CT
    • Pancreatic mass lying against the superior mesenteric artery
    • Three-dimensional CT vascular reconstruction
    • Portal and superior mesenteric veins on three-dimensional CT
    • Superior mesenteric artery on three-dimensional CT
    • Magnetic resonance imaging and cholangiopancreatography
    • Hypodense pancreatic head mass on contrast-enhanced MRI
    • Dilated bile and pancreatic ducts on magnetic resonance cholangiopancreatography
    • Endoscopic retrograde cholangiopancreatography
    • Indications for ERCP in periampullary cancer
    • Pancreatic and bile duct obstruction on ERCP
    • Completion cholangiogram after endoscopic stenting
    • Percutaneous cholangiography and positron emission tomography
    • Complete obstruction of the common bile duct on percutaneous cholangiography
    • Upper endoscopy and endoscopic ultrasound
    • Pancreatic head mass without vascular invasion on endoscopic ultrasound

    21 slides

  9. 09

    Tissue diagnosis

    When a biopsy changes the plan and when it does not

    • Tissue diagnosis before curative resection
    • Situations that do require tissue before treatment
    • Safety and yield of biopsy by site

    3 slides

  10. 10

    Preoperative biliary decompression

    Should the duct be drained before operating

    • Indications for preoperative biliary decompression
    • Evidence on preoperative biliary stenting

    2 slides

  11. 11

    Preoperative staging

    Deciding who should go to the operating room

    • Purpose and limits of staging imaging
    • Accuracy of three-dimensional CT in predicting resectability
    • Radiological signs of unresectability
    • Arguments for and against routine staging laparoscopy
    • Selective use of endoscopic ultrasound and laparoscopy
    • Clinicopathologic staging systems

    6 slides

  12. 12

    Pancreaticoduodenectomy

    The Whipple procedure, step by step

    • Sequence of pancreaticoduodenectomy
    • Incision, exposure and assessment of resectability
    • The Kocher maneuver
    • Bimanual palpation of the uncinate process
    • Relation of the uncinate process to the mesenteric vessels
    • Order of dissection and division of the bile duct
    • Gastroduodenal artery clamp test and division of the jejunum
    • Classic Whipple and pylorus-preserving variants
    • Exposure of the superior mesenteric vein
    • Developing the retropancreatic tunnel
    • Division of the pancreatic neck
    • Dissection of the uncinate process
    • Marking the resection margins
    • Order of reconstruction
    • Standard reconstruction after pancreaticoduodenectomy
    • Options for pancreatic reconstruction
    • Pancreaticogastrostomy reconstruction
    • Controversies in pancreatic reconstruction
    • Duct-to-mucosa anastomosis and duct stents
    • Invagination technique and pancreaticogastrostomy
    • Biliary and gastric anastomoses
    • Drains and postoperative management

    22 slides

  13. 13

    Distal pancreatectomy

    For cancer of the body or tail

    • Role of splenectomy with distal pancreatectomy
    • Exposure and entry into the lesser sac
    • Exposure of the pancreatic body and tail
    • Control of the splenic artery and vein
    • Transection of the pancreas and fistula prevention
    • Cancer of the body of the pancreas

    6 slides

  14. 14

    Operative palliation

    When cure is impossible but the abdomen is already open

    • Indications for operative palliation
    • The three problems palliation must solve
    • Operative palliation of obstructive jaundice
    • Technique of palliative hepaticojejunostomy
    • Anatomy after palliative bypass
    • Prophylactic gastrojejunostomy for duodenal obstruction
    • Technique of palliative gastrojejunostomy
    • Operative chemical splanchnicectomy for pain
    • Technique of alcohol celiac plexus block

    9 slides

  15. 15

    Nonoperative palliation

    Stents, blocks and analgesia

    • Proportion suitable for cure and routes of biliary drainage
    • Plastic and self-expanding metallic biliary stents
    • Selecting a stent and treating duodenal obstruction
    • Distal bile duct obstruction treated by metal stenting
    • Nonoperative palliation of pain

    5 slides

  16. 16

    Complications of resection

    What goes wrong and how often

    • 1.4%
    • Commonest complications after pancreaticoduodenectomy
    • Delayed gastric emptying
    • Postoperative pancreatic fistula
    • Complications after distal pancreatectomy

    5 slides

  17. 17

    Long-term survival

    What resection actually achieves

    • Composition of a resected periampullary series
    • Five-year survival by site of origin
    • Interpretation of survival and features of five-year survivors
    • Survival after resection of pancreatic cancer by tumour location
    • Survival by resection margin and lymph node status
    • Survival by tumour size and differentiation
    • Survival after 1423 pancreaticoduodenectomies
    • Prognostic factors in resected pancreatic cancer
    • Survival after resection of ampullary adenocarcinoma
    • Molecular prognosis and hospital volume

    10 slides

  18. 18

    Adjuvant therapy

    Treatment given after resection

    • Current state of adjuvant therapy
    • The GITSG adjuvant trial
    • Multiagent regimens and the gemcitabine comparison
    • The ESPAC-1 trial
    • The CONKO-001 trial
    • Survival with and without postoperative chemoradiation
    • Adjuvant therapy for non-pancreatic periampullary cancers

    7 slides

  19. 19

    Neoadjuvant therapy

    Treatment given before resection

    • Theoretical advantages of neoadjuvant therapy
    • The Duke University neoadjuvant series
    • The M.D. Anderson neoadjuvant programme
    • Preoperative chemoradiation trials for resectable pancreatic cancer
    • Preoperative chemoradiation trials at a single cancer centre
    • Reading the neoadjuvant trial results

    6 slides

  20. 20

    Novel agents in pancreatic cancer

    Targeting the molecular defects

    • Rationale for targeted agents
    • Basis and attractions of immune-based therapy
    • Phase I trial of a GM-CSF-secreting tumour vaccine
    • Bevacizumab in advanced pancreatic cancer
    • K-ras and farnesyltransferase inhibition
    • The epidermal growth factor receptor family
    • Trastuzumab in Her-2-positive pancreatic cancer
    • Erlotinib combined with gemcitabine

    8 slides

  21. 21

    Conclusion

    What to carry away

    • Summary of management principles
    • 15-20%
    • Pathway from presentation to treatment

    3 slides

  22. 22

    References

    Sources cited in this topic

    • References
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • Maingot's Abdominal Operations, 12th Edition

    12 slides